Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julie Jorns"'
Autor:
Nirit Mor-Vaknin, Anjan Saha, Maureen Legendre, Carmelo Carmona-Rivera, M Asif Amin, Bradley J. Rabquer, Marta J. Gonzales-Hernandez, Julie Jorns, Smriti Mohan, Srilakshmi Yalavarthi, Dave A. Pai, Kristine Angevine, Shelley J. Almburg, Jason S. Knight, Barbara S. Adams, Alisa E. Koch, David A. Fox, David R. Engelke, Mariana J. Kaplan, David M. Markovitz
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
DEK is a secreted protein abundant in the synovia of patients with juvenile idiopathic arthritis. Here the authors show DEK is important for neutrophil extracellular trap formation and joint inflammation, and demonstrate therapeutic efficacy of DEK-t
Externí odkaz:
https://doaj.org/article/2c912d0db4e646ad89d036163808223e
Autor:
Lubna Naaz Chaudhary, Julie Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind, MaryBeth Gonyo, Amanda Kong, Caitlin Patten, Tina Yen, Chandler Cortina, Ebony Carson, Nedra Johnson, Carmen Bergom, Shirng-Wern Tsaih, Anjishnu Banerjee, Yu Wang, Inna Chervoneva, Elizabeth Weil, Christopher R Chitambar, Hallgeir Rui
Background. Endocrine resistant metastatic disease develops in ~20-25% of hormone-receptor positive (HR+) breast cancer (BC) patients despite endocrine therapy (ET) use. Upregulation of HER family receptor tyrosine kinases (RTKs) represent escape mec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::248a572849afe55c1fb5987de5c5fd37
https://doi.org/10.21203/rs.3.rs-2777910/v1
https://doi.org/10.21203/rs.3.rs-2777910/v1
Publikováno v:
International Journal of Surgical Pathology. 30:590-592
We report a unique case of a post-menopausal female who presented with a lesion on the areola. A biopsy of the lesion demonstrated a pagetoid intraepithelial neoplasm suggesting a differential diagnosis of mammary Paget disease and pagetoid Bowen dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d3788b95f6a8437546cff6e30058d9
https://doi.org/10.1177/10668969221076550
https://doi.org/10.1177/10668969221076550
Autor:
Charles Robbins, Aileen Fernandez, Gan Han, Serena Wong, Malini Harigopal, Mirna Podoll, Kamaljeet Singh, Amy Ly, Maria Kuba, Hannah Wen, Mary Ann Sanders, Jane Brock, Shi Wei, Oluwole Fadare, Krisztina Hanley, Julie Jorns, Olivia Snir, Esther Yoon, Kim Rabe, T. Soong, Emily Reisenbichler, David Rimm
The HercepTest was approved 20 + years ago as the companion diagnostic test for trastuzumab in HER2 amplified/overexpressing breast cancers. Subsequent HER2 immunohistochemistry (IHC) assays followed, including the now most common Ventana 4B5 assay.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffa24fb3a7ce74b8a722f982469aa3a5
https://doi.org/10.21203/rs.3.rs-1763087/v1
https://doi.org/10.21203/rs.3.rs-1763087/v1